Aspire Biopharma Holdings Files 8-K Announcing Name Change

What Happened

• Aspire Biopharma Holdings, Inc. filed a Certificate of Amendment to its Certificate of Incorporation on September 8, 2026, changing the company name to “Aspire-Lakewood Holdings, Inc.” The amendment was effective the same day.
• The company also furnished a press release about the change on September 9, 2026.

Key Details

• Effective date of name change: September 8, 2026.
• New legal name: Aspire-Lakewood Holdings, Inc.
• Nasdaq trading symbol remains unchanged: "ASPB"; shares will continue to trade on The Nasdaq Capital Market.
• No stockholder approval was required under Delaware law (Sections 212 and 242); CUSIP and shareholder rights remain unchanged. No action is required by holders of book-entry shares or shares held through brokers/nominees.

Why It Matters

• This is a corporate name change only and does not alter shareholder ownership, rights, or the company’s Nasdaq listing—so investors should not expect any trading disruption.
• Investors don’t need to take action; existing stock certificates remain valid and the company’s CUSIP number is unchanged. The press release (filed as Exhibit 99.1) is available for any additional context the company provides about the change.